Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Head-to-Head asthma trial aims to find best way to stop attacks

NCT ID NCT06596512

First seen Mar 13, 2026 · Last updated May 26, 2026 · Updated 12 times

Summary

This study compares two proven asthma treatment plans—MART and PARTICS—to see which works better at preventing severe asthma attacks. About 4,100 adults with moderate-to-severe asthma who are at risk for flare-ups will take part. Participants will be randomly assigned to one of the two strategies and followed for 16 months via monthly surveys.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brigham and Womens Hospital

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Duke University

    Durham, North Carolina, 27705, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19122, United States

  • University of Wisconsin Madison

    Madison, Wisconsin, 53792, United States

  • Washington University

    St Louis, Missouri, 63110, United States

  • Yale University

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.